5 May 2026   May 4, 2026 Key Takeaways An executive order by the president could speed approvals and open new funding opportunities for psychedelic research into therapies for patients with serious mental illness. The DOJ published a final order rescheduling FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule III of […]